20/20 Biolabs, Inc. (AIDX) — Institutional Holders, Q2 2026
15 institutional investment managers reported a AIDX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $297.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
AIDX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- HRT FINANCIALNew · +89,273 sh+$49.1K
- VANGUARD FIDUCIARYNew · +52,087 sh+$28.6K
- GEODE CAPITAL MANAGEMENTNew · +49,141 sh+$27.0K
- Union BanksharesNew · +35,099 sh+$19.3K
- VANGUARD CAPITAL MANAGEMENTNew · +24,530 sh+$13.5K
Biggest sellers
- Cresset Asset ManagementTrimmed · -24,246 sh-$13.3K
- XTX Topco LtdSold out · -10,329 sh-$5.7K
- UBS Group AGTrimmed · -8,311 sh-$4.6K
- MAI Capital ManagementSold out · -1,000 sh-$550.00
- TOTH FINANCIAL ADVISORYTrimmed · -57 sh-$31.00
AIDX 13F holders ranked 1–15 of 15
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Cresset Asset Management#1 · 240,122 sh | 240,122 | $132.0K | <0.01% | -9.2% |
| 2 | HRT FINANCIAL#2 · 89,273 sh | 89,273 | $49.0K | <0.01% | New |
| 3 | VANGUARD FIDUCIARY#3 · 52,087 sh | 52,087 | $28.6K | 0.00% | New |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 49,141 sh | 49,141 | $27.0K | 0.00% | New |
| 5 | Union Bankshares#5 · 35,099 sh | 35,099 | $19.3K | <0.01% | New |
| 6 | VANGUARD CAPITAL MANAGEMENT#6 · 24,530 sh | 24,530 | $13.5K | 0.00% | New |
| 7 | CITADEL ADVISORS#7 · 23,205 sh | 23,205 | $12.8K | 0.00% | +43.0% |
| 8 | BANK OF AMERICA#8 · 13,024 sh | 13,024 | $7.2K | 0.00% | New |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#9 · 10,014 sh | 10,014 | $5.5K | 0.00% | New |
| 10 | MCDONALD PARTNERS#10 · 2,800 sh | 2,800 | $1.5K | <0.01% | New |
| 11 | SIGNATUREFD#11 · 767 sh | 767 | $422.00 | — | New |
| 12 | MORGAN STANLEY#12 · 283 sh | 283 | $156.00 | 0.00% | New |
| 13 | Allworth Financial#13 · 172 sh | 172 | $95.00 | 0.00% | +473.3% |
| 14 | TOTH FINANCIAL ADVISORY#14 · 100 sh | 100 | $55.00 | — | -36.3% |
| 15 | UBS Group AG#15 · 3 sh | 3 | $2.00 | 0.00% | -100.0% |
Funds that sold out of AIDX in Q2 2026 (2)
Held AIDX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd10,329 sh | 10,329 | $19.4K |
| MAI Capital Management1,000 sh | 1,000 | $1.9K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.